Nunaf Tablet

Nunaf Tablet is indicated for patients at high risk of dental decay, including those with xerostomia, orthodontic appliances, or a history of frequent cavities. Additionally, it may be used in the management of osteoporosis as a fluoride source to stimulate osteoblastic activity, although this is less common. The tablet is administered orally, with dosage tailored according to clinical need and patient age, ensuring optimal fluoride levels while minimizing the risk of toxicity.

Caution is advised in patients with renal impairment or hypersensitivity to fluoride compounds. Adverse effects are rare but may include gastrointestinal discomfort or dental fluorosis if overdosed. Nunaf Tablet should be used under medical supervision to ensure safe and effective fluoride supplementation. Regular dental check-ups are recommended to monitor treatment efficacy and oral health status.

This product is not intended for use in children under six years without professional guidance.